Aileron Therapeutics Stock Price on November 20, 2024
| ALRN Stock | USD 2.47 0.11 4.26% |
Below is the normalized historical share price chart for Aileron Therapeutics extending back to June 29, 2017. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Aileron Therapeutics stands at 2.47, as last reported on the 23rd of November, with the highest price reaching 2.69 and the lowest price hitting 2.33 during the day.
If you're considering investing in Aileron Stock, it is important to understand the factors that can impact its price. As of now, Aileron Stock is slightly risky. Aileron Therapeutics secures Sharpe Ratio (or Efficiency) of 0.0302, which signifies that the company had a 0.0302% return per unit of risk over the last 3 months. We have found thirty technical indicators for Aileron Therapeutics, which you can use to evaluate the volatility of the firm. Please confirm Aileron Therapeutics' Mean Deviation of 4.29, downside deviation of 5.08, and Risk Adjusted Performance of 0.0282 to double-check if the risk estimate we provide is consistent with the expected return of 0.18%.
At this time, Aileron Therapeutics' Total Stockholder Equity is very stable compared to the past year. As of the 23rd of November 2024, Common Stock is likely to grow to about 109.9 K, while Other Stockholder Equity is likely to drop about 171.5 M. . At this time, Aileron Therapeutics' Price Book Value Ratio is very stable compared to the past year. As of the 23rd of November 2024, Price Earnings To Growth Ratio is likely to grow to 0.02, while Price To Sales Ratio is likely to drop 0.14. Aileron Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 29th of June 2017 | 200 Day MA 3.7455 | 50 Day MA 3.4788 | Beta 2.341 |
Aileron |
Sharpe Ratio = 0.0302
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ALRN | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 5.99 actual daily | 53 53% of assets are less volatile |
Expected Return
| 0.18 actual daily | 3 97% of assets have higher returns |
Risk-Adjusted Return
| 0.03 actual daily | 2 98% of assets perform better |
Based on monthly moving average Aileron Therapeutics is performing at about 2% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Aileron Therapeutics by adding it to a well-diversified portfolio.
Price Book 1.0655 | Book Value 1.41 | Enterprise Value 36.2 M | Enterprise Value Ebitda (0.64) | Shares Float 19.4 M |
Aileron Therapeutics Main Headline on 20th of November 2024
Aileron Therapeutics Reports Q3 2024 Financial Results - MSN by news.google.com
Aileron Therapeutics Reports Q3 2024 Financial Results MSN
Aileron Therapeutics Valuation on November 20, 2024
It is possible to determine the worth of Aileron Therapeutics on a given historical date. On November 20, 2024 Aileron was worth 2.82 at the beginning of the trading date compared to the closed value of 2.76. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Aileron Therapeutics stock. Still, in general, we apply an absolute valuation method to find Aileron Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Aileron Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Aileron Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 2.88 | 3.09 | 2.74 | 2.82 | 40,619 | |
11/20/2024 | 2.82 | 3.11 | 2.59 | 2.76 | 115,020 |
| 2.73 | 2.85 | 2.50 | 2.58 | 104,309 |
| Backtest Aileron Therapeutics | | | Aileron Therapeutics History | | | Aileron Therapeutics Valuation | Previous | Next |
Aileron Therapeutics Trading Date Momentum on November 20, 2024
| On November 21 2024 Aileron Therapeutics was traded for 2.58 at the closing time. The top price for the day was 2.85 and the lowest listed price was 2.50 . The trading volume for the day was 104.3 K. The trading history from November 21, 2024 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 6.52% . The overall trading delta against the current closing price is 5.43% . |
Aileron Therapeutics Fundamentals Correlations and Trends
By evaluating Aileron Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Aileron Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Aileron financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Aileron Therapeutics Stock history
Aileron Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Aileron is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Aileron Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Aileron Therapeutics stock prices may prove useful in developing a viable investing in Aileron Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 4.6 M | 4.8 M | |
| Net Loss | -24.6 M | -25.8 M |
Aileron Therapeutics Quarterly Net Working Capital |
|
Aileron Therapeutics Stock Technical Analysis
Aileron Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Aileron Therapeutics Period Price Range
Low | November 23, 2024
| High |
0.00 | 0.00 |
Aileron Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Aileron Therapeutics November 23, 2024 Market Strength
Market strength indicators help investors to evaluate how Aileron Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Aileron Therapeutics shares will generate the highest return on investment. By undertsting and applying Aileron Therapeutics stock market strength indicators, traders can identify Aileron Therapeutics entry and exit signals to maximize returns
Aileron Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Aileron Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Aileron Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Aileron to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0282 | |||
| Jensen Alpha | 0.1336 | |||
| Total Risk Alpha | (0.81) | |||
| Sortino Ratio | 0.0045 | |||
| Treynor Ratio | 1.71 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aileron Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. To learn how to invest in Aileron Stock, please use our How to Invest in Aileron Therapeutics guide.You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aileron Therapeutics. If investors know Aileron will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aileron Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.88) | Return On Assets (0.26) | Return On Equity (0.44) |
The market value of Aileron Therapeutics is measured differently than its book value, which is the value of Aileron that is recorded on the company's balance sheet. Investors also form their own opinion of Aileron Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Aileron Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aileron Therapeutics' market value can be influenced by many factors that don't directly affect Aileron Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aileron Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Aileron Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aileron Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.